ZUTPHEN, the Netherlands, April 24, 2012 /PRNewswire/ --

In line with its continuous efforts to improve internal stem cell procedures, Cryo-Save proudly announces the appointment of the highly knowledgeable stem cell expert Dr. Marcin Jurga. Dr. Jurga will supervise new process validation at the Cryo-Save labs and study new processing techniques for umbilical cord blood, cord tissue and fat tissue, to ensure quality and use of the highest technology available on the market.

Marcin Jurga is specialized in adult stem cells biology, neuroscience and tissue engineering. His field of interest focuses on developing new methods for adult stem cell applications in in-vitro toxicology and regenerative medicine. Part of his validation study and internal research at Cryo-Save includes studies on fresh and frozen cells isolated from fat tissue and cord tissue, to explain the quality of these and their ability for extensive growth in vitro and multilineage differentiation.

"Cryo-Save is truly committed to the advancement of stem cell therapy. Storing stem cells is utterly important and our core business, but we are also committed to increasing the potential use of these stem cells and building the tools needed to tackle un-met medical needs with stem cells", said Arnoud Van Tulder, CEO of Cryo-Save.

Dr. Jurga is an experienced stem cell researcher with broad international experience; he was team leader and senior researcher at the Cell Therapy Research Institute in Lyon, France and previously completed a post doc at the Centre for Life, Newcastle University in the UK. He got Ph.D. degree in Poland, at the Mossakowski Medical Research Centre of Polish Academy of Sciences in Warsaw. In May, Dr. Jurga is also planning to get a habilitation degree at Lyon 1 Claude-Bernard University in France. The habilitation thesis entitled: "Stem Cell Therapy and Neutral Tissue Engineering in Regeneration of Central Nervous System".

Cryo-Save, the leading international family stem cell bank, stores more than 200,000 samples from umbilical cord blood, cord tissue and adipose tissue. There are already many diseases treatable by the use of stem cells, and the number of treatments will only increase. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).

Cryo-Save: http://www.cryo-save.com/group

Cryo-Save Group N.V.

1

Read the rest here:
Cryo-Save Hires Stem Cell Expert in the Flagship Lab in Niel, Belgium

Comments are closed.